
Drug Delivery Technologies Market Report 2024-2034
Description
Drug Delivery Technologies Market Report 2024-2034
The Drug Delivery Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The expansion observed in the drug delivery technologies sector can be largely attributed to several key drivers. These include the escalating prevalence of chronic ailments, the burgeoning biologics market, heightened investments in research and development, technological breakthroughs, and the introduction of novel products. Additionally, pharmaceutical and biopharmaceutical enterprises are strategically directing resources towards research and development endeavours aimed at cultivating new molecular entities tailored for diverse therapeutic applications and innovative drug delivery platforms. These companies are committed to substantial investments in research and development endeavours to ensure the delivery of superior-quality and ground-breaking products to the marketplace. Notably, the allocation of funds towards research and development by biopharmaceutical entities has witnessed a significant uptick over time. However, it's imperative to acknowledge potential constraints to market growth in the foreseeable future, such as the heightened risk of needlestick injuries and escalating pricing pressures.
What Questions Should You Ask before Buying a Market Research Report?
- How is the drug delivery technologies market evolving?
- What is driving and restraining the drug delivery technologies market?
- How will each drug delivery technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each drug delivery technologies submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading drug delivery technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the drug delivery technologies projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of
drug delivery technologies projects taking place now and over the next 10 years? - Is there a greater need for product commercialisation to further scale the drug delivery technologies market?
- Where is the drug delivery technologies market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
- Our 328-page report provides 121 tables, 184 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Route of Administration
- Implantable Drug Delivery
- Injectable Drug Delivery
- Nasal Drug Delivery
- Ocular Drug Delivery
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Topical Drug Delivery
- Transmucosal Drug Delivery
- Cancer
- Cardiovascular
- Diabetes
- Infectious Diseases
- Others
- Ambulatory Surgical Centres
- Hospitals
- Home Care Settings
- Others
North America
- U.S.
- Canada
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- BD
- Boehringer Ingelheim
- Boston Scientific Corporation
- Bristol-Myers Squibb
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Gerresheimer AG
- Gilead Sciences, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Teva Pharmaceuticals Industries Ltd.
How will the Drug Delivery Technologies Market, 2024 to 2034 report help you?
In summary, our 320+ page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Drug Delivery Technologies Market 2024 to 2034, with forecasts for route of administration, application, and end-users each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 21 key national markets – See forecasts for the Drug Delivery Technologies Market, 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 19 of the major companies involved in the Drug Delivery Technologies Market, 2024 to 2034.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Delivery Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
Table of Contents
328 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Drug Delivery Technologies Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Rising Prevalence of Chronic Diseases
- 3.2.1.2 Technological Advancements Driving Industry Growth
- 3.2.1.3 Rising Focus on Patient-centric Care
- 3.2.1.4 Integration of AI and Big Data
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Lack of Awareness and Infrastructure
- 3.2.2.2 Risk of Needlestick Injuries
- 3.2.2.3 Reimbursement Issues in Advanced Drug Delivery Technologies
- 3.2.3 Market Opportunities
- 3.2.3.1 Self-administration and Home Care
- 3.2.3.2 Digital Integration and Connectivity
- 3.2.3.3 Expanding Applications in Biologics and Gene Therapies
- 3.2.3.4 Sustainable and Eco-friendly Innovations in Drug Delivery Technologies
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter’s Five Forces Analysis
- 3.4.1 Supplier Power
- 3.4.2 Buyer Power
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat of Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
- 4 Drug Delivery Technologies Market Analysis by Route of Administration
- 4.1 Key Findings
- 4.2 Route of Administration Segment: Market Attractiveness Index
- 4.3 Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 4.4 Implantable Drug Delivery
- 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
- 4.5 Injectable Drug Delivery
- 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)
- 4.6 Nasal Drug Delivery
- 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.6.2 Market Share by Region, 2024 & 2034 (%)
- 4.7 Ocular Drug Delivery
- 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.7.2 Market Share by Region, 2024 & 2034 (%)
- 4.8 Oral Drug Delivery
- 4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.8.2 Market Share by Region, 2024 & 2034 (%)
- 4.9 Pulmonary Drug Delivery
- 4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.9.2 Market Share by Region, 2024 & 2034 (%)
- 4.10 Topical Drug Delivery
- 4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.10.2 Market Share by Region, 2024 & 2034 (%)
- 4.11 Transmucosal Drug Delivery
- 4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.11.2 Market Share by Region, 2024 & 2034 (%)
- 5 Drug Delivery Technologies Market Analysis by Application
- 5.1 Key Findings
- 5.2 Application Segment: Market Attractiveness Index
- 5.3 Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 5.4 Cancer
- 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
- 5.5 Cardiovascular
- 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
- 5.6 Diabetes
- 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
- 5.7 Infectious Diseases
- 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)
- 5.8 Others
- 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.8.2 Market Share by Region, 2024 & 2034 (%)
- 6 Drug Delivery Technologies Market Analysis by End-users
- 6.1 Key Findings
- 6.2 End-users Segment: Market Attractiveness Index
- 6.3 Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 6.4 Ambulatory Surgical Centres
- 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
- 6.5 Hospitals
- 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
- 6.6 Home Care Settings
- 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.6.2 Market Share by Region, 2024 & 2034 (%)
- 6.7 Others
- 6.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.7.2 Market Share by Region, 2024 & 2034 (%)
- 7 Drug Delivery Technologies Market Analysis by Region
- 7.1 Key Findings
- 7.2 Regional Market Size Estimation and Forecast
- 8 North America Drug Delivery Technologies Market Analysis
- 8.1 Key Findings
- 8.2 North America Drug Delivery Technologies Market Attractiveness Index
- 8.3 North America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 8.4 North America Drug Delivery Technologies Market Size Estimation and Forecast by Country
- 8.5 North America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 8.6 North America Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 8.7 North America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 8.8 U.S. Drug Delivery Technologies Market Analysis
- 8.9 Canada Drug Delivery Technologies Market Analysis
- 9 Europe Drug Delivery Technologies Market Analysis
- 9.1 Key Findings
- 9.2 Europe Drug Delivery Technologies Market Attractiveness Index
- 9.3 Europe Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 9.4 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Country
- 9.5 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 9.6 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 9.7 Europe Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 9.8 Germany Drug Delivery Technologies Market Analysis
- 9.9 UK Drug Delivery Technologies Market Analysis
- 9.10 France Drug Delivery Technologies Market Analysis
- 9.11 Italy Drug Delivery Technologies Market Analysis
- 9.12 Spain Drug Delivery Technologies Market Analysis
- 9.13 Russia Drug Delivery Technologies Market Analysis
- 9.14 Rest of Europe Drug Delivery Technologies Market Analysis
- 10 Asia Pacific Drug Delivery Technologies Market Analysis
- 10.1 Key Findings
- 10.2 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
- 10.3 Asia Pacific Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 10.4 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Country
- 10.5 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 10.6 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 10.7 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 10.8 Japan Drug Delivery Technologies Market Analysis
- 10.9 China Drug Delivery Technologies Market Analysis
- 10.10 India Drug Delivery Technologies Market Analysis
- 10.11 Australia Drug Delivery Technologies Market Analysis
- 10.12 South Korea Drug Delivery Technologies Market Analysis
- 10.13 South-East Asia Drug Delivery Technologies Market Analysis
- 10.14 Rest of Asia Pacific Drug Delivery Technologies Market Analysis
- 11 Latin America Drug Delivery Technologies Market Analysis
- 11.1 Key Findings
- 11.2 Latin America Drug Delivery Technologies Market Attractiveness Index
- 11.3 Latin America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 11.4 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Country
- 11.5 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 11.6 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 11.7 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 11.8 Brazil Drug Delivery Technologies Market Analysis
- 11.9 Mexico Drug Delivery Technologies Market Analysis
- 11.10 Rest of Latin America Drug Delivery Technologies Market Analysis
- 12 MEA Drug Delivery Technologies Market Analysis
- 12.1 Key Findings
- 12.2 MEA Drug Delivery Technologies Market Attractiveness Index
- 12.3 MEA Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 12.4 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Country
- 12.5 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
- 12.6 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Application
- 12.7 MEA Drug Delivery Technologies Market Size Estimation and Forecast by End-users
- 12.8 GCC Drug Delivery Technologies Market Analysis
- 12.9 South Africa Drug Delivery Technologies Market Analysis
- 12.10 Rest of MEA Drug Delivery Technologies Market Analysis
- 13 Company Profiles
- 13.1 Johnson & Johnson Services, Inc.
- 13.1.1 Company Snapshot
- 13.1.2 Company Overview
- 13.1.3 Financial Analysis
- 13.1.3.1 Net Revenue, 2015-2023
- 13.1.3.2 Regional Market Shares, 2023
- 13.1.3.3 R&D, 2015-2023
- 13.1.4 Product Benchmarking
- 13.2 Novartis AG
- 13.2.1 Company Snapshot
- 13.2.2 Company Overview
- 13.2.3 Financial Analysis
- 13.2.3.1 Net Revenue, 2015-2023
- 13.2.3.2 Regional Market Shares, 2023
- 13.2.3.3 R&D, 2015-2023
- 13.2.4 Product Benchmarking
- 13.2.5 Strategic Outlook
- 13.3 F. Hoffmann-La Roche Ltd.
- 13.3.1 Company Snapshot
- 13.3.2 Company Overview
- 13.3.3 Financial Analysis
- 13.3.3.1 Net Revenue, 2015-2023
- 13.3.3.2 Regional Market Shares, 2023
- 13.3.3.3 R&D, 2015-2023
- 13.3.4 Product Benchmarking
- 13.3.5 Strategic Outlook
- 13.4 Pfizer Inc.
- 13.4.1 Company Snapshot
- 13.4.2 Company Overview
- 13.4.3 Financial Analysis
- 13.4.3.1 Net Revenue, 2015-2023
- 13.4.3.2 Regional Market Shares, 2023
- 13.4.3.3 R&D, 2015-2023
- 13.4.4 Product Benchmarking
- 13.4.5 Strategic Outlook
- 13.5 Bayer AG
- 13.5.1 Company Snapshot
- 13.5.2 Company Overview
- 13.5.3 Financial Analysis
- 13.5.3.1 Net Revenue, 2015-2022
- 13.5.3.2 Regional Market Shares, 2022
- 13.5.3.3 R&D, 2015-2022
- 13.5.4 Product Benchmarking
- 13.5.5 Strategic Outlook
- 13.6 Becton, Dickinson and Company
- 13.6.1 Company Snapshot
- 13.6.2 Company Overview
- 13.6.3 Financial Analysis
- 13.6.3.1 Net Revenue, 2015-2023
- 13.6.3.2 Regional Market Shares, 2023
- 13.6.3.3 R&D, 2015-2023
- 13.6.4 Product Benchmarking
- 13.6.5 Strategic Outlook
- 13.7 GSK plc
- 13.7.1 Company Snapshot
- 13.7.2 Company Overview
- 13.7.3 Financial Analysis
- 13.7.3.1 Net Revenue, 2015-2023
- 13.7.3.2 Regional Market Shares, 2023
- 13.7.3.3 R&D, 2015-2023
- 13.7.4 Product Benchmarking
- 13.8 Merck & Co., Inc.
- 13.8.1 Company Snapshot
- 13.8.2 Company Overview
- 13.8.3 Financial Analysis
- 13.8.3.1 Net Revenue, 2015-2023
- 13.8.3.2 Regional Market Shares, 2023
- 13.8.3.3 R&D, 2015-2023
- 13.8.4 Product Benchmarking
- 13.8.5 Strategic Outlook
- 13.9 Sanofi
- 13.9.1 Company Snapshot
- 13.9.2 Company Overview
- 13.9.3 Financial Analysis
- 13.9.3.1 Net Revenue, 2015-2023
- 13.9.3.2 Regional Market Shares, 2023
- 13.9.3.3 R&D, 2015-2023
- 13.9.4 Product Benchmarking
- 13.9.5 Strategic Outlook
- 13.10 Amgen Inc.
- 13.10.1 Company Snapshot
- 13.10.2 Company Overview
- 13.10.3 Financial Analysis
- 13.10.3.1 Net Revenue, 2015-2023
- 13.10.3.2 R&D, 2015-2023
- 13.10.3.3 Regional Market Shares, 2023
- 13.10.4 Product Benchmarking
- 13.10.5 Strategic Outlook
- 13.11 AbbVie Inc.
- 13.11.1 Company Snapshot
- 13.11.2 Company Overview
- 13.11.3 Financial Analysis
- 13.11.3.1 Net Revenue, 2015-2023
- 13.11.3.2 Regional Market Shares, 2023
- 13.11.3.3 R&D, 2015-2023
- 13.11.4 Product Benchmarking
- 13.11.5 Strategic Outlook
- 13.12 Gilead Sciences, Inc.
- 13.12.1 Company Snapshot
- 13.12.2 Company Overview
- 13.12.3 Financial Analysis
- 13.12.3.1 Net Revenue, 2015-2023
- 13.12.3.2 R&D, 2015-2023
- 13.12.4 Product Benchmarking
- 13.12.5 Strategic Outlook
- 13.13 Boehringer Ingelheim
- 13.13.1 Company Snapshot
- 13.13.2 Company Overview
- 13.13.3 Financial Analysis
- 13.13.3.1 Net Revenue, 2015-2022
- 13.13.3.2 Regional Market Shares, 2022
- 13.13.4 Product Benchmarking
- 13.14 AstraZeneca plc
- 13.14.1 Company Snapshot
- 13.14.2 Company Overview
- 13.14.3 Financial Analysis
- 13.14.3.1 Net Revenue, 2015-2023
- 13.14.3.2 Regional Market Shares, 2023
- 13.14.3.3 R&D, 2015-2022
- 13.14.4 Product Benchmarking
- 13.14.5 Strategic Outlook
- 13.15 Eli Lilly and Company
- 13.15.1 Company Snapshot
- 13.15.2 Company Overview
- 13.15.3 Financial Analysis
- 13.15.3.1 Net Revenue, 2015-2022
- 13.15.3.2 Regional Market Shares, 2023
- 13.15.3.3 R&D, 2015-2022
- 13.15.4 Product Benchmarking
- 13.15.5 Strategic Outlook
- 13.16 Teva Pharmaceuticals Industries Ltd.
- 13.16.1 Company Snapshot
- 13.16.2 Company Overview
- 13.16.3 Financial Analysis
- 13.16.3.1 Net Revenue, 2015-2022
- 13.16.3.2 Regional Market Shares, 2023
- 13.16.3.3 R&D, 2015-2022
- 13.16.4 Product Benchmarking
- 13.16.5 Strategic Outlook
- 13.17 Bristol-Myers Squibb
- 13.17.1 Company Snapshot
- 13.17.2 Company Overview
- 13.17.3 Financial Analysis
- 13.17.3.1 Net Revenue, 2015-2022
- 13.17.3.2 Regional Market Shares, 2023
- 13.17.3.3 R&D, 2015-2022
- 13.17.4 Product Benchmarking
- 13.18 Gerresheimer AG
- 13.18.1 Company Snapshot
- 13.18.2 Company Overview
- 13.18.3 Financial Analysis
- 13.18.3.1 Net Revenue, 2015-2023
- 13.18.3.2 Regional Market Shares, 2023
- 13.18.4 Product Benchmarking
- 13.18.5 Strategic Outlook
- 13.19 Boston Scientific Corporation
- 13.19.1 Company Snapshot
- 13.19.2 Company Overview
- 13.19.3 Financial Analysis
- 13.19.3.1 Net Revenue, 2015-2022
- 13.19.3.2 Regional Market Shares, 2023
- 13.19.3.3 R&D, 2015-2022
- 13.19.4 Product Benchmarking
- 13.19.5 Strategic Outlook
- 14 Conclusion and Recommendations
- 14.1 Concluding Remarks from Visiongain
- 14.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.